Dr Reddy's gets 2 observations from USFDA for New York API plant

Dr. Reddy's Laboratories announced that the USFDA issued a Form 483 with two observations after a GMP inspection of its API manufacturing facility in Middleburgh, New York. The inspection, conducted between May 12-16, 2025, identified potential violations of the Food Drug and Cosmetic Act.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/pfM1h8q
via IFTTT